Evidence map›Paper›PMID 23359283›Full record

ArticleThe Journal of general physiology2013

Opening the shaker K+ channel with hanatoxin.

Mirela Milescu, Hwa C Lee, Chan Hyung Bae, Jae Il Kim, Kenton J Swartz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Current computer-aided drug design · 2025
    Article
  3. Neuronomodulation of Excitable Neurons.Neuroscience bulletin · 2024
    Review
  4. Peptide Toxins Targeting KV Channels.Handbook of experimental pharmacology · 2021
    Review
  5. KFrontiers in cellular neuroscience · 2020
    Review
  6. Article
  7. Review
  8. The tarantula toxin GxTx detains KThe Journal of general physiology · 2019
    Article
  9. Unlocking the gating mechanism of Kv2.1 using guangxitoxin.The Journal of general physiology · 2019
    Article
  10. Deglycosylation of Shaker KThe Journal of general physiology · 2018
    Article
  11. Heat activation is intrinsic to the pore domain of TRPV1.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Structural interactions of a voltage sensor toxin with lipid membranes.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  20. Chemoselective tarantula toxins report voltage activation of wild-type ion channels in live cells.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mirela MilescuMolecular Physiology and Biophysics Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Hwa C Lee
Chan Hyung Bae
Jae Il Kim
Kenton J Swartz
Gwangju Institute of Science and Technology · KRNational Institutes of Health · USNational Institute of Neurological Disorders and Stroke · US

Funding

Gating mechanisms and pharmacology of voltage-activated ion channelsZIANS002945 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SWARTZ, KENTON · 2009 to 2025
$44.2M
PROBING THE STRUCTURE AND FUNCTION OF POTASSIUM AND CALCIUM CHANNELSZ01NS002945 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI SWARTZ, KENTON J · 1997 to 2008
$1.9M
Intramural NIH HHS Z01 NS002945NINDS NIH HHS NS002945-16
6 · The paper itself

Abstract

Voltage-activated ion channels open and close in response to changes in membrane voltage, a property that is fundamental to the roles of these channels in electrical signaling. Protein toxins from venomous organisms commonly target the S1-S4 voltage-sensing domains in these channels and modify their gating properties. Studies on the interaction of hanatoxin with the Kv2.1 channel show that this tarantula toxin interacts with the S1-S4 domain and inhibits opening by stabilizing a closed state. Here we investigated the interaction of hanatoxin with the Shaker Kv channel, a voltage-activated channel that has been extensively studied with biophysical approaches. In contrast to what is observed in the Kv2.1 channel, we find that hanatoxin shifts the conductance-voltage relation to negative voltages, making it easier to open the channel with membrane depolarization. Although these actions of the toxin are subtle in the wild-type channel, strengthening the toxin-channel interaction with mutations in the S3b helix of the S1-S4 domain enhances toxin affinity and causes large shifts in the conductance-voltage relationship. Using a range of previously characterized mutants of the Shaker Kv channel, we find that hanatoxin stabilizes an activated conformation of the voltage sensors, in addition to promoting opening through an effect on the final opening transition. Chimeras in which S3b-S4 paddle motifs are transferred between Kv2.1 and Shaker Kv channels, as well as experiments with the related tarantula toxin GxTx-1E, lead us to conclude that the actions of tarantula toxins are not simply a product of where they bind to the channel, but that fine structural details of the toxin-channel interface determine whether a toxin is an inhibitor or opener.

Indexed as

AnimalsCells, CulturedIon Channel GatingMembrane PotentialsOocytesPeptidesPotassium Channel BlockersShaker Superfamily of Potassium ChannelsXenopus laevishanatoxinPeptidesPotassium Channel BlockersShaker Superfamily of Potassium Channels

Identifiers

PMID23359283
PMCPMC3557313
OpenAlexW2128745322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.